146 related articles for article (PubMed ID: 8645083)
1. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies.
Streckert HJ; Philippou S; Riedel F
Arch Virol; 1996; 141(3-4):401-10. PubMed ID: 8645083
[TBL] [Abstract][Full Text] [Related]
2. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis.
Dakhama A; Vitalis TZ; Hegele RG
Eur Respir J; 1997 Jan; 10(1):20-6. PubMed ID: 9032486
[TBL] [Abstract][Full Text] [Related]
3. A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo.
Chargelegue D; Obeid OE; Hsu SC; Shaw MD; Denbury AN; Taylor G; Steward MW
J Virol; 1998 Mar; 72(3):2040-6. PubMed ID: 9499058
[TBL] [Abstract][Full Text] [Related]
4. Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs.
Hegele RG; Hayashi S; Bramley AM; Hogg JC
Chest; 1994 Jun; 105(6):1848-54. PubMed ID: 8205887
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo.
Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR
J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985
[TBL] [Abstract][Full Text] [Related]
6. Persistence of airway hyperresponsiveness and viral antigen following respiratory syncytial virus bronchiolitis in young guinea-pigs.
Riedel F; Oberdieck B; Streckert HJ; Philippou S; Krusat T; Marek W
Eur Respir J; 1997 Mar; 10(3):639-45. PubMed ID: 9072998
[TBL] [Abstract][Full Text] [Related]
7. Enhanced pulmonary pathology associated with the use of formalin-inactivated respiratory syncytial virus vaccine in cotton rats is not a unique viral phenomenon.
Piedra PA; Wyde PR; Castleman WL; Ambrose MW; Jewell AM; Speelman DJ; Hildreth SW
Vaccine; 1993 Nov; 11(14):1415-23. PubMed ID: 7508665
[TBL] [Abstract][Full Text] [Related]
8. Protection against respiratory syncytial virus infection by DNA immunization.
Li X; Sambhara S; Li CX; Ewasyshyn M; Parrington M; Caterini J; James O; Cates G; Du RP; Klein M
J Exp Med; 1998 Aug; 188(4):681-8. PubMed ID: 9705950
[TBL] [Abstract][Full Text] [Related]
9. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.
Johnson TR; Johnson JE; Roberts SR; Wertz GW; Parker RA; Graham BS
J Virol; 1998 Apr; 72(4):2871-80. PubMed ID: 9525607
[TBL] [Abstract][Full Text] [Related]
10. Production of acute bronchiolitis in guinea-pigs by human respiratory syncytial virus.
Hegele RG; Robinson PJ; Gonzalez S; Hogg JC
Eur Respir J; 1993 Oct; 6(9):1324-31. PubMed ID: 8287949
[TBL] [Abstract][Full Text] [Related]
11. Passive protection of gnotobiotic calves using monoclonal antibodies directed at different epitopes on the fusion protein of bovine respiratory syncytial virus.
Thomas LH; Cook RS; Wyld SG; Furze JM; Taylor G
J Infect Dis; 1998 Apr; 177(4):874-80. PubMed ID: 9534958
[TBL] [Abstract][Full Text] [Related]
12. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology.
Walzl G; Tafuro S; Moss P; Openshaw PJ; Hussell T
J Exp Med; 2000 Nov; 192(9):1317-26. PubMed ID: 11067880
[TBL] [Abstract][Full Text] [Related]
13. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
Spender LC; Hussell T; Openshaw PJ
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
[TBL] [Abstract][Full Text] [Related]
14. Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection.
Gaddum RM; Cook RS; Wyld SG; López JA; Bustos R; Melero JA; Taylor G
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1239-48. PubMed ID: 8683212
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
[TBL] [Abstract][Full Text] [Related]
16.
van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
[TBL] [Abstract][Full Text] [Related]
17. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.
Tripp RA; Moore D; Winter J; Anderson LJ
J Virol; 2000 Feb; 74(4):1614-22. PubMed ID: 10644330
[TBL] [Abstract][Full Text] [Related]
18. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of recombinant measles vaccine expressing fusion protein of respiratory syncytial virus in cynomolgus monkeys.
Sawada A; Yunomae K; Nakayama T
Microbiol Immunol; 2018 Feb; 62(2):132-136. PubMed ID: 29194753
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
Larios Mora A; Detalle L; Van Geelen A; Davis MS; Stohr T; Gallup JM; Ackermann MR
PLoS One; 2015; 10(12):e0143580. PubMed ID: 26641081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
